Current Neuropharmacology

Current Neuropharmacology

当前的神经药理学

  • 2区 中科院分区
  • Q1 JCR分区

期刊简介

《Current Neuropharmacology》是由Bentham Science Publishers B.V.出版社于2003年创办的英文国际期刊(ISSN: 1570-159X,E-ISSN: 1875-6190),该期刊长期致力于药学领域的创新研究,主要研究方向为医学-神经科学。作为SCIE收录期刊(JCR分区 Q1,中科院 2区),本刊采用OA未开放获取模式(OA占比0%),以发表药学领域等方向的原创性研究为核心(研究类文章占比26.09%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在161篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Current Neuropharmacology审稿周期约为 12周,或约稿 。该刊近年未被列入国际预警名单,年发文量约161篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 161 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
PHARMACOLOGY & PHARMACY 药学 NEUROSCIENCES 神经科学
2区 3区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
NEUROSCIENCES 神经科学 PHARMACOLOGY & PHARMACY 药学
2区 2区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:NEUROSCIENCES SCIE Q1 57 / 310

81.8%

学科:PHARMACOLOGY & PHARMACY SCIE Q1 50 / 354

86%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:NEUROSCIENCES SCIE Q2 126 / 310

59.52%

学科:PHARMACOLOGY & PHARMACY SCIE Q2 112 / 354

68.5%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:8.7 SJR:1.299 SNIP:1.277
学科类别 分区 排名 百分位
大类:Medicine 小类:Pharmacology (medical) Q1 30 / 272

89%

大类:Medicine 小类:Psychiatry and Mental Health Q1 63 / 567

88%

大类:Medicine 小类:Neurology (clinical) Q1 54 / 400

86%

大类:Medicine 小类:Neurology Q1 28 / 192

85%

大类:Medicine 小类:Pharmacology Q1 55 / 313

82%

期刊发文

  • Comparative Analysis of the Pre- and Post-Medication Effects of Antipsychotic Agents on the Blood-Based Oxidative Stress Biomarkers in Patients with Schizophrenia: A Meta-Analysis

    Author: Yang, Mi; Wang, Chunzhi; Zhao, Guocheng; Kong, Di; Liu, Liju; Yuan, Shuai; Chen, Wei; Feng, Can; Li, Zezhi

    Journal: CURRENT NEUROPHARMACOLOGY. 2023; Vol. 21, Issue 2, pp. 340-352. DOI: 10.2174/1570159X20666220706101021

  • New Insights of Early Brain Injury after Subarachnoid Hemorrhage: A Focus on the Caspase Family

    Author: Wang, Xiaoyu; Xu, Penglei; Liu, Yibo; Wang, Zefeng; Lenahan, Cameron; Fang, Yuanjian; Lu, Jianan; Zheng, Jingwei; Wang, Kaikai; Wang, Wei; Zhou, Jingyi; Chen, Sheng; Zhang, Jianming

    Journal: CURRENT NEUROPHARMACOLOGY. 2023; Vol. 21, Issue 2, pp. 392-408. DOI: 10.2174/1570159X20666220420115925

  • Early Efficacy of Antipsychotic Medications at Week 2 Predicts Subsequent Responses at Week 6 in a Large-scale Randomized Controlled Trial

    Author: Tang, Yiguo; Wu, Yulu; Li, Xiaojing; Hao, QinJian; Deng, Wei; Yue, Weihua; Yan, Hao; Zhang, Yamin; Tan, Liwen; Chen, Qi; Yang, Guigang; Lu, Tianlan; Wang, Lifang; Yang, Fude; Zhang, Fuquan; Yang, Jianli; Li, Keqing; Lv, Luxian; Tan, Qingrong; Zhang, Hongyan; Ma, Xin; Li, Lingjiang; Wang, Chuanyue; Ma, Xiaohong; Zhang, Dai; Yu, Hao; Zhao, Liansheng; Ren, Hongyan; Wang, Yingcheng; Zhang, Guangya; Li, Chuanwei; Du, Xiangdong; Hu, Xun; Li, Tao; Wang, Qiang

    Journal: CURRENT NEUROPHARMACOLOGY. 2023; Vol. 21, Issue 2, pp. 424-436. DOI: 10.2174/1570159X21666221118164612

  • Effect of Repetitive Transcranial Magnetic Stimulation in Inducing Weight Loss in Patients with Chronic Schizophrenia: A Randomized, Double-Blind Controlled 4-Week Study

    Author: Su, Xiuru; Wang, Xuan; Pan, Xiuling; Zhang, Xuan; Lu, Xinyan; Zhao, Long; Chen, Yingnan; Shang, Yujie; Zhu, Lin; Lu, Shulan; Zhu, Xiaolin; Wu, Fengchun; Xiu, Meihong

    Journal: CURRENT NEUROPHARMACOLOGY. 2023; Vol. 21, Issue 2, pp. 417-423. DOI: 10.2174/1570159X20666220524123315

  • Neuronavigated Repetitive Transcranial Stimulation Improves Neurocognitive Functioning in Veterans with Schizophrenia: A Possible Role of BDNF Polymorphism

    Author: Su, Xiuru; Liu, Haixia; Wang, Xuan; Pan, Xiuling; Zhang, Xuan; Lu, Xinyan; Zhao, Long; Chen, Yingnan; Shang, Yujie; Wu, Fengchun; Xiu, Meihong

    Journal: CURRENT NEUROPHARMACOLOGY. 2023; Vol. 21, Issue 1, pp. 142-150. DOI: 10.2174/1570159X20666220803154820

  • Energy Crisis Links to Autophagy and Ferroptosis in Alzheimer's Disease: Current Evidence and Future Avenues

    Author: He, Da-Long; Fan, Yong-Gang; Wang, Zhan-You

    Journal: CURRENT NEUROPHARMACOLOGY. 2023; Vol. 21, Issue 1, pp. 67-86. DOI: 10.2174/1570159X20666220817140737

  • Epilepsy and Autism Spectrum Disorder (ASD): The Underlying Mechanisms and Therapy Targets Related to Adenosine

    Author: Guo, Mengyi; Xie, Pandeng; Liu, Siqi; Luan, Guoming; Li, Tianfu

    Journal: CURRENT NEUROPHARMACOLOGY. 2023; Vol. 21, Issue 1, pp. 54-66. DOI: 10.2174/1570159X20666220706100136

  • Prevention and Treatment for Chemotherapy-Induced Peripheral Neuropathy: Therapies Based on CIPN Mechanisms.

    Author: Hu LY1, Mi WL1, Wu GC1, Wang YQ1, Mao-Ying QL1.

    Journal: Curr Neuropharmacol. 2019;17(2):184-196. doi: 10.2174/1570159X15666170915143217.